Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema.
about
Candidate genes for COPD: current evidence and researchThe short and long telomere syndromes: paired paradigms for molecular medicinePersonalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGeneAutomatic tissue characterization of air trapping in chest radiographs using deep neural networks.Integrative genomics of chronic obstructive pulmonary disease.Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitusReduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk.Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitationBody mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease.Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.Year in review 2014. Paediatric and adult clinical studies.Subtyping Chronic Obstructive Pulmonary Disease Using Peripheral Blood Proteomics.Identifying Patients With COPD at High Risk of Readmission.Correlation Between Emphysema and Lung Function in Healthy Smokers and Smokers With COPD.Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts.Risk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions.A Bayesian Nonparametric Model for Disease Subtyping: Application to Emphysema Phenotypes.Genome-Wide Association Study of the Genetic Determinants of Emphysema Distribution.A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease.Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients.NHLBI Strategic Visioning: setting an agenda together for the NHLBI of 2025.NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025.Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression.A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups.The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study.Use of metabotyping for the delivery of personalised nutrition.Evaluation of the visit frequency and the use of questionnaires and indices for COPD: a national survey from the On-Sint study.Imaging biomarkers in the clinic.Clean Fuels to Reduce Household Air Pollution and Improve Health. Still Hoping to Answer Why and How.Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
P2860
Q26777324-1331B445-4042-4D62-ADF1-E612721DEB59Q26800388-17FD5704-2417-4C81-A6BF-E5C7D9C84AA3Q27027259-8BF02F9A-7C1F-404C-B6F6-8738CA1011EAQ28383674-32D5AF26-22EB-4712-80DD-AAA3370FBCA5Q33764829-0CF61447-C96C-4BB0-AFE8-ED81EFF5F387Q34232677-068275F2-EA0C-48E6-A840-D9C8F1B702CEQ34436462-F70EAB6D-E7E0-4AB1-9523-EE175D28573BQ35565173-FC9E20F7-275F-4856-9A95-D643E4D09873Q35637182-8462A1A2-BE5C-4BBD-85F0-9A0E22267975Q35805903-689073C9-C49E-4601-9AD3-3E469A3BE52DQ36907742-60F5F4EF-98B5-4C7E-836D-06AF16CDFDA8Q38376166-5E68D311-9ED6-40D9-B1A3-A45F3F87780DQ38604607-CCA0F0A6-CADE-49AB-B51C-3D08207412EEQ38604624-FFC51238-6421-4A36-BAEF-0E5CEE68AF31Q38604667-7EAD9693-5CBC-474A-A29B-2691FF258594Q38715004-ED3E38B3-4B8C-4143-8312-D228540747FFQ38827548-E3A44023-8D70-484F-84FB-B10DD6C99F4FQ39004803-7D20B480-F7BD-400D-B275-B5CF465AF13BQ39351123-BFA87233-7FA5-4C5F-A919-75CEAF5AAC6DQ41112661-6B0664BC-D370-4128-8047-0B9675A59692Q41493817-CFF90AFB-C8EA-4F0F-8821-811C19BAC8D1Q41522898-76726F46-EB54-4CA8-8B8D-39AD56731B7EQ42591123-0A4452BF-BF7E-4442-AE00-D1568EDC2855Q43216278-40D602BD-C80D-49EA-A2F3-82BCBAF92188Q45945497-2C58A9DF-33BE-4B1A-8C2D-A7E5FBEBE374Q47170520-CCA6BF57-DF47-4601-A8A1-8921BDE9128AQ47745623-390922AD-3EFA-4C12-88E7-813B3498FCEAQ51034019-C1C959C5-7707-4B4B-8A7E-1769FF698634Q51615224-DB96FBC3-CE90-4047-8E0C-A4DFBEC7FA2FQ53028581-1121AF50-27E6-4D0A-8F52-1A017868139EQ55341285-11890A02-CB49-43D6-9046-DE5B882D4F79Q58725160-12D530F1-EE6A-4FD5-A45A-2A531A680F54
P2860
Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cluster analysis in the COPDGe ...... airway disease and emphysema.
@en
Cluster analysis in the COPDGe ...... airway disease and emphysema.
@nl
type
label
Cluster analysis in the COPDGe ...... airway disease and emphysema.
@en
Cluster analysis in the COPDGe ...... airway disease and emphysema.
@nl
prefLabel
Cluster analysis in the COPDGe ...... airway disease and emphysema.
@en
Cluster analysis in the COPDGe ...... airway disease and emphysema.
@nl
P2093
P2860
P50
P1433
P1476
Cluster analysis in the COPDGe ...... airway disease and emphysema.
@en
P2093
Andre Williams
Barry J Make
Craig P Hersh
David A Lynch
Dawn L DeMeo
Edwin K Silverman
Edwin van Beek
Elizabeth A Regan
George R Washko
Gerald J Criner
P2860
P304
P356
10.1136/THORAXJNL-2013-203601
P407
P577
2014-02-21T00:00:00Z